Authors: Hanel, M Kroger, N Kroschinsky, F Birkmann, J Hanel, A Herbst, R Naumann, R Friedrichsen, K Ehninger, G Zander, AR Fiedler, F

Citation: M. Hanel et al., Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma, J CANC RES, 127(6), 2001, pp. 387-395

Authors: Goerner, M Wandt, H Schafer-Eckart, K Birkmann, J Denzel, T Gallmeier, WM

Citation: M. Goerner et al., The use of CD34(+)-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications, J HEMATH ST, 8(4), 1999, pp. 387-391

Authors: Wandt, H Birkmann, J Denzel, T Schafer, K Schwab, G Pilz, D Egger, H Both, A Gallmeier, WM

Citation: H. Wandt et al., Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer, BONE MAR TR, 23(8), 1999, pp. 763-770

Authors: Buschel, G Kaiser, G Weiger, M Weigang, K Birkmann, J Gallmeier, WM

Citation: G. Buschel et al., Best-case analyses of 4 current unconventional therapies in ontology, FORSCH KOMP, 5, 1998, pp. 68-71